GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » IR-Med Inc (OTCPK:IRME) » Definitions » YoY EBITDA Growth

IRME (IR-Med) YoY EBITDA Growth : 72.22% (As of Dec. 2024)


View and export this data going back to 2021. Start your Free Trial

What is IR-Med YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. IR-Med's YoY EBITDA Growth for the quarter that ended in Dec. 2024 was 72.22%.

IR-Med's EBITDA per Share for the three months ended in Dec. 2024 was $-0.01.

IR-Med YoY EBITDA Growth Historical Data

The historical data trend for IR-Med's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

IR-Med YoY EBITDA Growth Chart

IR-Med Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24
YoY EBITDA Growth
- -436.36 -18.64 -1.43 61.97

IR-Med Quarterly Data
Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 37.93 55.00 68.75 52.94 72.22

IR-Med YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

IR-Med's YoY EBITDA Growth for the fiscal year that ended in Dec. 2024 is calculated as:

YoY EBITDA Growth (A: Dec. 2024 )
=(EBITDA per Share (A: Dec. 2024 )-EBITDA per Share (A: Dec. 2023 ))/ | EBITDA per Share (A: Dec. 2023 ) |
=(-0.027--0.071)/ | -0.071 |
=61.97 %

IR-Med's YoY EBITDA Growth for the quarter that ended in Dec. 2024 is calculated as:

YoY EBITDA Growth (Q: Dec. 2024 )
=(EBITDA per Share (Q: Dec. 2024 )-EBITDA per Share (Q: Dec. 2023 )) / | EBITDA per Share (Q: Dec. 2023 )) |
=(-0.005--0.018)/ | -0.018 |
=72.22 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

IR-Med YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of IR-Med's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

IR-Med Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » IR-Med Inc (OTCPK:IRME) » Definitions » YoY EBITDA Growth
Comparable Companies
TNON SINT FOFA STME DHAI AEMD MOVE WOK AIMD GTHP ABT BSX SYK MDT XTER:SHL EW SZSE:300760 DXCM XAMS:PHIA STE
Traded in Other Exchanges
N/A
Address
Z.H.R Industrial Zone, P.O. Box 143, Rosh Pina, ISR, 1231400
Website
https://www.ir-medical.com
IR-Med Inc is a development stage medical device company developing its technology through its Subsidiary and is utilizing Infra-Red-light spectroscopy (IR) combined with Artificial Intelligence (AI) technology platform to develop non-invasive devices for various medical indications, by detecting and measuring various biomarkers and molecules in the blood and in human tissue in real-time.